版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
1、HDL and Coronary Heart DiseasePhysiology and Pathophysiology of HDL MetabolismHDL and Coronary Heart DiseaseStructure of HDL ParticleA-IA-IA-IIA-I, A-II = apolipoprotein A-I, A-II; CE = cholesteryl ester; TG = triglyceridesCETGStructure of HDL ParticleA-IA-Production of HDL by Liver and IntestineA-I
2、A-IA-IIA-I, A-II = apolipoprotein A-I, A-IILiverIntestineHDLHDLProduction of HDL by Liver andHDL Metabolism and Reverse Cholesterol TransportA-ILiverCECECEFCFCLCATFCBileSR-BIA-IABC1 = ATP-binding cassette protein 1; A-I = apolipoprotein A-I; CE = cholesteryl ester; FC = free cholesterol; LCAT = leci
3、thin:cholesterol acyltransferase; SR-BI = scavenger receptor class BIABC1MacrophageMature HDLNascent HDLHDL Metabolism and Reverse ChRole of CETP in HDL MetabolismA-ILiverCECEFCFCLCATFCBileSR-BIA-IABC1MacrophageCEBCETP = cholesteryl ester transfer proteinLDL = low-density lipoprotein LDLR = low-dens
4、ity lipoprotein receptorVLDL = very-low-density lipoproteinLDLRVLDL/LDLCETPMature HDLNascent HDLCESRAOxidationRole of CETP in HDL MetabolismRole of Hepatic Lipase and Lipoprotein Lipase in HDL MetabolismCM = chylomicron; CMR = chylomicron remnant; HDL = high-density lipoprotein; HL = hepatic lipase;
5、 IDL = intermediate-density lipoprotein; LPL = lipoprotein lipase; PL = phospholipase; TG = triglycerideBKidneyEndotheliumBTGCMR/IDLC-IICM/VLDLHLLPLA-ICE TGHDL2PLA-ICEHDL3PLPhospholipids and apolipoproteinsRole of Hepatic Lipase and LipPrimary (Genetic) Causes of Low HDL-CApoA-IComplete apoA-I defic
6、iencyApoA-I mutations (eg, ApoA-IMilano) LCATComplete LCAT deficiencyPartial LCAT deficiency (fish-eye disease)ABC1Tangier diseaseHomozygousHeterozygous Familial hypoalphalipoproteinemia (some families)Unknown genetic etiologyFamilial hypoalphalipoproteinemia (most families) Familial combined hyperl
7、ipidemia with low HDL-CMetabolic syndromePrimary (Genetic) Causes of LoComplete ApoA-I DeficiencyMarkedly reduced HDL-C levels and absent apoA-ICutaneous xanthomas (some patients)Premature atherosclerotic vascular disease (some patients)Complete ApoA-I DeficiencyMarkApoA-I MutationsModest to marked
8、reduction in HDL-C and apoA-IRapid catabolism of apoA-ISystemic amyloidosis Premature atherosclerotic disease (rare)ApoA-I MutationsModest to markLCAT Deficiency and Fish-eye DiseaseBoth due to mutations in LCAT gene:LCAT deficiency completeFish-eye disease partialCommon to both types of LCAT defici
9、ency: Markedly reduced HDL-C and apoA-I levelsRapid catabolism of apoA-I and apoA-IICorneal arcusPremature atherosclerotic vascular disease (rare)Unique to complete LCAT deficiency:Proteinuria and progressive renal insufficiencyLCAT Deficiency and Fish-eye DHDL Metabolism in LCAT DeficiencyA-IFCFCLC
10、ATA-IABC1MacrophageRapid catabolismNascent HDLCEHDL Metabolism in LCAT DeficieTangier DiseaseAutosomal codominant disorder due to mutations in both alleles of ABC1 geneExtremely marked reduction in HDL-C and apoA-I Markedly accelerated catabolism of apoA-I and apoA-IICholesterol accumulation:Enlarge
11、d orange tonsilsHepatosplenomegalyPeripheral neuropathyTangier DiseaseAutosomal codomTangier Disease(Continued)Increased risk of premature atherosclerotic vascular diseasePathologic accumulation of cholesterol in macrophages and other cells of reticulo-endothelial systemHeterozygotes have moderately
12、 reduced HDL-C and apoA-I levels and increased risk of premature atherosclerotic vascular disease, but no tonsillar enlargement or hepatosplenomegalyTangier Disease(Continued)IncHDL Metabolism in Tangier DiseaseA-IFCFCA-IABC1MacrophageRapid catabolismLCATNascent HDLCEHDL Metabolism in Tangier DiseFa
13、milial HypoalphalipoproteinemiaDominant disorder; due to mutations in one allele of ABC1 gene in some families, and of unknown genetic etiology in other familiesModerate reduction in HDL-C and apoA-IIncreased risk of premature atherosclerotic vascular diseaseFamilial HypoalphalipoproteineSecondary C
14、auses of Low HDL-CSmokingObesity (visceral fat)Very-low-fat dietHypertriglyceridemiaDrugsBeta-blockers Androgenic steroidsAndrogenic progestinsSecondary Causes of Low HDL-CSPrimary (Genetic) Causes of High HDL-CCETPCETP deficiencyHepatic lipaseHepatic lipase deficiencyUnknown genetic etiologyFamilia
15、l hyperalphalipoproteinemiaPrimary (Genetic) Causes of HiCETP DeficiencyAutosomal co-dominant; due to mutations in both alleles of CETP geneMarkedly elevated levels of HDL-C and apoA-IDelayed catabolism of HDL cholesteryl ester and apoA-IHDL particles enlarged and enriched in cholesteryl esterNo evi
16、dence of protection against atherosclerosis; possible increased risk of premature atherosclerotic vascular diseaseCETP DeficiencyAutosomal co-doHDL Metabolism in CETP DeficiencyA-ICEFCFCLCATA-IMacrophageBDelayed catabolismCETPABC1HDLVLDL/LDLNascent HDLCEHDL Metabolism in CETP DeficieHepatic Lipase D
17、eficiencyAutosomal recessive, due to mutations in both alleles of hepatic lipase geneModestly elevated levels of HDL-C and apoA-IVariable elevations in total cholesterol, triglycerides, and lipoprotein remnant particlesNo evidence of protection against atherosclerosis; possible increased risk of pre
18、mature atherosclerotic vascular diseaseHepatic Lipase DeficiencyAutosHDL Metabolism in Hepatic Lipase DeficiencyA-ILiverA-ICE TGCEHLDelayed catabolismHDL2HDL3HDL Metabolism in Hepatic LipFamilial HyperalphalipoproteinemiaAutosomal dominant; molecular etiology unknownModest to marked elevations in HD
19、L-C and apoA-ISelective increased synthesis of apoA-I in some familiesAssociated with longevity and protection against atherosclerotic vascular disease in epidemiologic studiesFamilial HyperalphalipoproteinSecondary Causes of Increased HDL-CExtensive regular aerobic exerciseVery-high-fat dietRegular
20、 substantial alcohol intakeEstrogen replacement therapyDrugsPhenytoinSecondary Causes of Increased Genes Involved in HDL MetabolismPotential Targets for Development of Novel Therapies for Atherosclerosis HDL-associated apolipoproteins ApoA-I ApoE ApoA-IV HDL-modifying plasma enzymes and transfer pro
21、teins LCAT Lipoprotein lipase CETP Hepatic lipase PLTP Endothelial lipaseCellular and cell-surface proteins that influence HDL metabolism ABC1 SR-BIGenes Involved in HDL MetaboliGene Transfer of ApoA-I to Liver Induces Regression of Atherosclerosis in LDLR/ Mice012345BaselineAdnullAortic lesion (%)A
22、dhapoA-I* P 0.05Tangirala R et al. Circulation 1999;100:18161822Gene Transfer of ApoA-I to LivOverexpression of LCAT Prevents Development of Atherosclerosis in Transgenic Rabbits* P 0.003LCAT = lecithin-cholesterol acyltransferase; Tg = transgenicHoeg JM et al. Proc Natl Acad Sci U S A. 1996;93:1144811453Copyright 1996 National Academy of Sciences, USA
溫馨提示
- 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 2024年南京客運(yùn)考試口訣是什么意思
- 2024年郴州考從業(yè)資格證客運(yùn)試題
- 2024年安徽煙臺(tái)客運(yùn)上崗證考試題
- 2024年西藏駕校客運(yùn)從業(yè)資格證模擬考試題
- 抗病毒藥物行業(yè)競(jìng)爭(zhēng)格局與投資戰(zhàn)略研究咨詢報(bào)告
- 2024年南京客運(yùn)資格證專業(yè)知識(shí)試題及答案
- 2024年阜陽(yáng)客運(yùn)資格證仿真試題
- 在線AI教育行業(yè)投資機(jī)會(huì)分析與策略研究報(bào)告
- 企業(yè)風(fēng)險(xiǎn)保險(xiǎn)行業(yè)發(fā)展趨勢(shì)及前景展望分析報(bào)告
- 抗感染藥物行業(yè)消費(fèi)者群體特征分析
- 7年級(jí)數(shù)學(xué)培訓(xùn)課件
- 2024年中谷海運(yùn)集團(tuán)有限公司招聘筆試參考題庫(kù)附帶答案詳解
- 2022版義務(wù)教育(信息科技)課程標(biāo)準(zhǔn)(附課標(biāo)解讀)
- 2019年現(xiàn)代化工HSE競(jìng)賽桌面推演案例題
- 營(yíng)業(yè)執(zhí)照租賃協(xié)議保證金條款
- 2024年10月自考03312勞動(dòng)和社會(huì)保障概論押題及答案
- 2024年1月浙江首考讀后續(xù)寫-2024屆高考英語(yǔ)作文復(fù)習(xí)
- 基藥培訓(xùn)課件模板
- 振戎中學(xué)九年級(jí)提質(zhì)專項(xiàng)方案
- 超聲炮治療方案
- 超越自我做最好的自己主題班會(huì)課件
評(píng)論
0/150
提交評(píng)論